Production (Stage)
AEON Biopharma, Inc.
AEON
$0.534
-$0.015-2.73%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 169.12M | 42.01M | 13.68M | -305.52M | -485.01M |
| Total Depreciation and Amortization | 91.00K | 97.00K | 98.00K | 100.00K | 99.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -183.61M | -63.10M | -40.43M | 269.99M | 442.73M |
| Change in Net Operating Assets | -5.20M | 706.00K | -4.04M | -7.96M | -3.18M |
| Cash from Operations | -19.60M | -20.29M | -30.69M | -43.40M | -45.37M |
| Capital Expenditure | -4.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4.00K | -- | -- | -- | -- |
| Total Debt Issued | 10.00M | 15.00M | 15.00M | 15.00M | 13.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 18.49M | 147.00K | 50.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 28.49M | 15.15M | 15.05M | 15.00M | 13.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.89M | -5.15M | -15.64M | -28.40M | -32.37M |